Advisory Board
Learn and Connect with C5’s Life Sciences IP Portfolio Advisory Board.
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.
Advisory Board
Heidi Adler
Director, Intellectual Property Rights Orion Corporation
Brigitte Carion-Taravella, PhD
Principal Patent Counsel, Lead Biologics IP EU and EU Patent Policy Sanofi (France)
Monika Dorda
SVP & General Counsel Global Pharmaceuticals GSK
Holger J. Dulat
VP IP Affimed
Sabrina Duschner
VP Patent Litigation Strategy Fresenius Kabi
Julia Pike
Global IP Head Sandoz
Guido Pontremoli, Ph.D.
Global IP HeadCorp. Intellectual Property-Patents Chiesi Farmaceutici S.p.A.
Karin Pramberger
Head of IP Polpharma Group
Laura Reynolds
Associate General CounselEuropean IP and Regulatory Litigation Teva Pharmaceuticals
Jiri Slavik
Vice President, IP Adalvo (Czech Republic)Emeritus Members
Dominic Adair
Partner Bristows LLP (U.K)